Recent advancement, immune responses, and mechanism of action of various vaccines against intracellular bacterial infections
Emerging and re-emerging bacterial infections are a serious threat to human and animal
health. Extracellular bacteria are free-living, while facultative intracellular bacteria replicate …
health. Extracellular bacteria are free-living, while facultative intracellular bacteria replicate …
[HTML][HTML] Regulation of CD8 T cell by B-cells: A narrative review
T Van Meerhaeghe, A Néel, S Brouard… - Frontiers in …, 2023 - frontiersin.org
Activation of CD4 T cells by B cells has been extensively studied, but B cell-regulated
priming, proliferation, and survival of CD8 T cells remains controversial. B cells express high …
priming, proliferation, and survival of CD8 T cells remains controversial. B cells express high …
[PDF][PDF] Vaccine adjuvant-elicited CD8+ T cell immunity is co-dependent on T-bet and FOXO1
DL Ivanova, SB Thompson, J Klarquist, MG Harbell… - Cell reports, 2023 - cell.com
T-bet and FOXO1 are transcription factors canonically associated with effector and memory
T cell fates, respectively. During an infectious response, these factors direct the development …
T cell fates, respectively. During an infectious response, these factors direct the development …
[HTML][HTML] IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohort
TF Spracklen, SC Mendelsohn, C Butters… - Frontiers in …, 2022 - frontiersin.org
Introduction Multisystem inflammatory syndrome in children (MIS-C) is a severe acute
inflammatory reaction to SARS-CoV-2 infection in children. There is a lack of data describing …
inflammatory reaction to SARS-CoV-2 infection in children. There is a lack of data describing …
Interferon α facilitates anti-HBV cellular immune response in a B cell-dependent manner
S Zhong, Q Li, C Wen, Y Li, Y Zhou, Z Jin, G Ye… - Antiviral Research, 2022 - Elsevier
Objectives Dissecting the underlying mechanism of T cells remodeling mediated by
interferon α (IFN-α) is indispensable for achieving an optimum therapeutic response in …
interferon α (IFN-α) is indispensable for achieving an optimum therapeutic response in …
[HTML][HTML] Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab
E Groß-Albenhausen, A Weier, M Velten… - Frontiers in …, 2023 - frontiersin.org
Introduction Since the development of the coronavirus disease (COVID-19) pandemic
caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), there has …
caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), there has …
Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell Crosstalk
Current cancer vaccines using T cell epitopes activate antitumor T cell immunity through
dendritic cell/macrophage-mediated antigen presentation, but they lack the ability to …
dendritic cell/macrophage-mediated antigen presentation, but they lack the ability to …
Significance of intratumoral infiltration of B cells in cancer immunotherapy: From a single cell perspective
S Gu, L Qian, Y Zhang, K Chen, Y Li, J Wang… - Biochimica et Biophysica …, 2021 - Elsevier
Immunotherapy for cancer has provided new treatment approaches for malignant tumors,
but there are low rates of response and high rates of resistance. The most recent …
but there are low rates of response and high rates of resistance. The most recent …
mRNA Vaccines Contribute to Innate and Adaptive Immunity to Enhance Immune Response In Vivo
Messenger RNA (mRNA) therapeutics have been widely employed as strategies for the
treatment and prevention of diseases. Amid the global outbreak of COVID-19, mRNA …
treatment and prevention of diseases. Amid the global outbreak of COVID-19, mRNA …
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose
Introduction Chimeric antigen receptor T (CAR-T) cell immunotherapy has revolutionized the
prognosis of refractory or relapsed B-cell malignancies. CAR-T cell recipients have …
prognosis of refractory or relapsed B-cell malignancies. CAR-T cell recipients have …